Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
Introduction. There has been a recent trend toward a gradual increase in the incidence of rectal cancer and a decrease in the average age of patients. These changes interpret the need to personalize treatment in each case.Objective – to evaluate the association of polymorphic variants of some genes...
Saved in:
Main Authors: | V. A. Grigorenko, E. P. Kulikov, S. A. Mertsalov, Yu. D. Kaminsky, A. A. Nikiforov, A. I. Sudakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-07-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/355 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01) -
Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Liangjing Zhou, et al.
Published: (2025-07-01) -
Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
by: WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
Published: (2025-04-01) -
Tumor Response to Neoadjuvant Long-Course Chemoradiotherapy Depends on the Rectal Cancer Patient Gender
by: Velda Smajlbegović, et al.
Published: (2024-01-01) -
Neoadjuvant chemotherapy versus long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis of 5,168 cases
by: Wenjie Zhou, et al.
Published: (2025-06-01)